D. Sperbeck

发表

Ibrexafungerp: an orally active β-1,3-glucan synthesis inhibitor.

P. Liberator, M. Motyl, M. Peel, 2020, Bioorganic & medicinal chemistry letters.

MK-5204: An orally active β-1,3-glucan synthesis inhibitor.

P. Liberator, M. Motyl, M. Peel, 2020, Bioorganic & medicinal chemistry letters.

Discovery of MK-8831, A Novel Spiro-Proline Macrocycle as a Pan-Genotypic HCV-NS3/4a Protease Inhibitor.

Rebecca T. Ruck, Yongxin Han, J. Howe, 2016, ACS medicinal chemistry letters.

The effect of heteroatom substitution on a series of phosphonate inhibitors of neutral endopeptidase 24.11

G. Ksander, Reynalda de Jesus, J. Stanton, 1994 .

Potent DGAT1 Inhibitors in the Benzimidazole Class with a Pyridyl-oxy-cyclohexanecarboxylic Acid Moiety.

Shirly Pinto, J. Lisnock, R. DeVita, 2013, ACS medicinal chemistry letters.

Heterocyclic lactam derivatives as dual angiotensin converting enzyme and neutral endopeptidase 24.11 inhibitors.

J. Stanton, D. Sperbeck, R. Ghai, 1993, Journal of medicinal chemistry.

Practical syntheses of a novel tricyclic dipeptide mimetic based on a [6H]-azepino indoline nucleus: Application to angiotensin-converting enzyme inhibition

D. Sperbeck, T. M. Jenson, S. D. Lombaert, 1994 .

Triazolo-tetrahydrofluorenones as selective estrogen receptor beta agonists.

S. Nilsson, A. Thorsell, L. Colwell, 2006, Bioorganic & medicinal chemistry letters.

Benzimidazole-based DGAT1 inhibitors with a [3.1.0] bicyclohexane carboxylic acid moiety.

Shirly Pinto, M. Reibarkh, R. DeVita, 2019, Bioorganic & medicinal chemistry letters.

Discovery of a Potent and Selective DGAT1 Inhibitor with a Piperidinyl-oxy-cyclohexanecarboxylic Acid Moiety.

Shirly Pinto, J. Lisnock, R. DeVita, 2014, ACS medicinal chemistry letters.

Accelerating the discovery of DGAT1 inhibitors through the application of parallel medicinal chemistry (PMC).

Shirly Pinto, R. Nargund, P. Váchal, 2019, Bioorganic & medicinal chemistry letters.

Practical Syntheses of a Novel Tricyclic Dipeptide Mimetic Based on a ( 6H)-Azepino Indoline Nucleus: Application to Angiotensin-Converting Enzyme Inhibition.

D. Sperbeck, T. M. Jenson, S. D. Lombaert, 1995 .

Secondary amides of (R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionic acid as inhibitors of pyruvate dehydrogenase kinase.

T D Aicher, J L Stanton, J Gao, 2000, Journal of medicinal chemistry.

Microscale High-Throughput Experimentation as an Enabling Technology in Drug Discovery: Application in the Discovery of (Piperidinyl)pyridinyl-1H-benzimidazole Diacylglycerol Acyltransferase 1 Inhibitors.

Andreas Verras, Yang Yu, Edward C Sherer, 2017, Journal of medicinal chemistry.

Effects of metalloprotease inhibitors on the conversion of proendothelin-1 to endothelin-1.

A. Jeng, R. Lappe, J. Balwierczak, 1993, Biochemistry and molecular biology international.